Levêque D, Gallion-Renault C, Monteil H, Jehl F
Laboratory of Antibiology, University Hospital Center, Louis-Pasteur University, Strasbourg, France.
J Chromatogr A. 1998 Jul 31;815(2):163-72. doi: 10.1016/s0021-9673(98)00452-x.
Our previous review on the liquid chromatographic (LC) analysis of anti-bacterial agents was published in 1990 in a special issue of the Journal of Chromatography. Eight years later, some new agents have been registered and numerous other are under clinical experiment. In spite of therapeutic problems encountered with certain bacterial pathogens, the development of novel drug candidates has slowed partially due to the need for identification of new bacterial targets and the cost of the research. The present overview updates the LC methods for the quantitations of recent antimicrobial agents (marketed and in clinical development) in human biological fluids. Consideration has been given to procedures permitting the determination of isomers and metabolites as well as methods regarding tissue extracts or liquid sampled from physiological sanctuaries. LC methods are available for the quantitation of almost all registered or investigated recent anti-infective drugs and some are applicable in routine practice. Nevertheless, few techniques have been validated for the determination in tissue extracts limiting the development of penetration studies.
我们之前关于抗菌剂液相色谱(LC)分析的综述于1990年发表在《色谱杂志》的一期特刊上。八年后,一些新的抗菌剂已注册,还有许多其他抗菌剂正在进行临床试验。尽管某些细菌病原体存在治疗问题,但由于需要确定新的细菌靶点以及研究成本,新型候选药物的研发有所放缓。本综述更新了用于定量分析人体生物流体中近期抗菌剂(已上市和正在临床开发)的LC方法。已考虑到允许测定异构体和代谢物的程序以及有关组织提取物或从生理保护区采集的液体样本的方法。LC方法可用于定量几乎所有已注册或研究的近期抗感染药物,有些方法适用于常规实践。然而,很少有技术经过验证可用于组织提取物的测定,这限制了渗透研究的开展。